Google Übersetzer
Delcath Systems Inc
About
Delcath Systems Inc (NASDAQ:DCTH) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 23 2026
Delcath Systems to Host First Quarter 2026 Earnings Call
Apr 6 2026
Delcath Systems, Inc. Announces Inclusion of CHEMOSAT Hepatic Delivery System for Melphalan as a Recommended Liver-Directed Regional Therapy Option in the ESMO–EURACAN Clinical Practice Guidelines for Uveal Melanoma
Apr 1 2026
Delcath Systems to Participate at the Society of Interventional Radiology 2026 Meeting
Mar 3 2026
Delcath Systems Announces Publication of CHOPIN Clinical Trial Results in The Lancet Oncology
Feb 26 2026
Delcath Systems Reports Fourth Quarter and Full Year 2025 Results
Financials
Revenue
$85.23 M
Market Cap
$340.07 M
P/E Ratio
137.57
EPS
0.07